CN Health Tech Rights Issue Sees 28.62% Take-Up; 71.38% of Shares Head to Market Placing

Bulletin Express06-16

China Health Technology Group Holding Company Limited (CN Health Tech) announced the results of its two-for-one rights issue, revealing a low subscription rate that shifts most of the new shares to a market placing process.

Key figures • Issued share capital on record date: 102.92 million shares. • Rights shares offered: 205.85 million. • Valid acceptances received: 58.92 million rights shares, representing 28.62% of the offer. • Unsubscribed rights shares: 146.93 million, or 71.38% of the offer, to be disposed of through a placing on a best-effort basis.

Post-subscription capital structure After allotting the accepted rights shares, total issued shares rise to 161.84 million. Major shareholder Ms. Huang Hou’s absolute holding remains at 8.06 million shares, but her stake is diluted from 7.83% to 4.98%. Public shareholders increase their collective holding from 92.17% to 95.02%.

Next steps and timetable • Share certificates for fully-paid rights shares are scheduled to be mailed on 17 June 2026. • Trading in the new shares is expected to begin at 09:00 on 18 June 2026. • The placing agent has until 16:00 on 6 July 2026 to place the 146.93 million unsubscribed shares at not less than the subscription price. Any shares left unplaced will be cancelled, reducing the final size of the rights issue.

Risk reminder Completion of both the rights issue and the placing remains conditional on several factors, with final confirmation expected by 7 July 2026. Investors transacting in CN Health Tech shares before that date bear the risk that either transaction may not proceed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment